A new perfume project needs a clear brief, technical feasibility review, assigned regulatory responsibilities and defined approval gates. The workflow here is a proposal to agree with the project team, not proof of a factory’s exact SOP, turnaround or turnkey compliance service.
What Triggers a Factory Review?
A brief can start a feasibility discussion before every detail is known. Record the target countries/channels, intended use, sensory goals, budget and proposed quantities, then identify open decisions and the owner of each.
Step 1 – Brief Feasibility Check
Ask the commercial and technical teams to confirm the following within their actual scope:
- Fragrance family and complexity. Is it a straightforward fruity floral or a complex oriental with rare naturals? Availability and cost of raw materials shape feasibility early.
- Cost scope: Distinguish concentrate, finished liquid, filled bottle, decoration, validation and shipment costs; provide a clearly defined target rather than unsupported $15/$60-per-liter comparisons.
- Actual carrier/base and concentration. Whether you need Eau de Toilette, Eau de Parfum, or an oil‑based roll‑on affects formulation parameters and regulatory filing later.
- Packaging compatibility. Agree who reviews the actual bottle/pump/cap assembly, formula and relevant fit/function evidence.
Ask for a written feasibility response identifying unsupported requests, unavailable materials, cost assumptions and regulatory questions. A particular scent family does not by itself establish an impossible budget.
Step 2 – Regulatory and Market Compliance Screening
Name the qualified reviewer for each destination and distinguish in-house work, subcontracted work and assistance. Review the actual formula, intended use, claims and supply arrangement rather than assuming the factory handles every obligation:
- Fragrance information: Review applicable supplier conformity information for the selected mixture/use and amendment scope; it is not finished-product safety or market approval.
- Country responsibilities: Confirm the actual EU, US or other destination requirements and responsible roles. EU CPNP is notification, not registration approval.
- Allergen/ingredient review: Have the technical reviewer assess the complete final formula against current destination rules, thresholds and transition conditions. Do not aim merely to stay below labeling thresholds or rely on an outdated universal 26-allergen list. For EU changes see Regulation 2023/1545, checked 10 October 2026.
- Claims: Define exact wording and meaning, supporting evidence and any voluntary certification scope; the factory’s statement alone does not validate every claim.
For EU cosmetics, identify the EU-established responsible person and the required safety/product file, notification and labeling work using the Cosmetics Regulation. For US cosmetics, identify applicable roles, exemptions and evidence using FDA MoCRA guidance. Other countries require their own current review; no generic “Middle East SASO certificate” route is imposed. Official sources checked 10 October 2026.
Step 3 – Fragrance Profile and Match Review
Use an independently described scent brief, rights-cleared reference or mood board to request coded samples. The proposed perfumery role and evaluation method should be agreed, not assumed:
- Reference comparison: Describe opening, heart, drydown, sweetness, diffusion and other agreed attributes using coded samples. No 85–95% similarity figure is meaningful here without a defined method and data, and no exact duplication or IP clearance is promised.
- Final-use behavior: Define the intended appearance and sensory criteria and agree the relevant formula/package evidence.
- Performance: Specify dose, conditions and evaluation period for any wear/projection claim; adding fixatives or concentration does not automatically achieve it.
A sensory approval freezes only the identified sample and scope. Record the formula/sample version and any open final-package, safety, stability or process work. A scent approval alone does not make a formula production-ready.
Step 4 – Packaging Engineering Check
Have the qualified engineering team review the selected formula and complete packaging assembly. Agree applicable checks rather than prescribing one universal compatibility test:
- Mechanical assembly: Review drawings, pickup geometry, actuation, cap clearance and closure-appropriate leakage checks.
- Material interaction: Identify contact parts and agree relevant formula/material methods, conditions and acceptance limits.
- Process feasibility: Confirm equipment fit, setup, handling and trial requirements for the actual assembly.
- Labeling space and legibility. Legal texts, batch code, and ingredient list must fit without looking cramped. Assign qualified destination-market label review separately from the factory’s confirmed design or production scope.
Supply the relevant drawings, component codes, materials and artwork versions so the team can identify what remains missing. No fixed weeks-saving is established by a complete brief.
Step 5 – Pilot Batch and Quality Assurance
Select any pilot or line trial through the project risk and process review. Quantity, configuration, methods and approval criteria must be agreed; no 10–50-liter or few-hundred-unit factory standard is verified here.
- Process comparison: Assess the proposed scale and setup against approved acceptance criteria; no pilot guarantees absence of drift.
- Microbiological controls: Use a qualified formula/package/process risk assessment; carrier name or water content alone does not prescribe the tests.
- Stability: Agree conditions, sampling points and criteria for the actual formula/package; no universal 4/25/40°C panel is imposed.
- Final filled sample: Record exactly what the approval covers. Any later change reopens affected checks rather than becoming automatically prohibited or accepted.
Set the pilot schedule from the actual scope, materials and evidence plan. No 4–6-week duration or guarantee against rejection is established.
What the Factory Expects from You
Complete the fields below and identify open assumptions before asking the team to freeze a development or production plan:
| Buyer brief field | Fill in | Team output / owner / freeze gate |
|---|---|---|
| Countries, channels and intended use | ___ | Applicability and responsibility matrix / reviewer ___ / market brief freeze |
| Sensory direction and reference rights | ___ | Coded sample plan / perfumery owner ___ / sensory reference freeze |
| Defined cost target and quantity allocation | ___ | Conditional quote and minimums / commercial owner ___ / order approval |
| Bottle, pump, cap and artwork revisions | ___ | Engineering/label gaps / reviewers ___ / package and artwork freeze |
| Exact claims and desired certifications | ___ | Evidence and scope decision / qualified reviewer ___ / claims approval |
| Requested timing and dependencies | ___ | Confirmed milestone plan / project owner ___ / schedule baseline |
| Pilot and release needs | ___ | Evidence, deviations and sign-offs / quality owner ___ / production release |
FAQ
How long does a typical factory review take?
Confirm a project-specific schedule. LAEYO’s owner-confirmed sample R&D reference is about three days excluding communication, confirmation and transport; revisions, validation and production are separate. No 8–12-week approval path or mandatory two rounds is promised.
Can I use my own bottle and just have the factory fill it?
Ask whether customer-supplied components are accepted for the proposed project. Agree drawings/samples, inspection and trial scope, quantities, ownership, rejection/rework costs and schedule consequences before sending them.
What if I don’t have a reference fragrance? Can the factory create something from a description?
A descriptive brief can be used to propose sample directions, subject to confirmed project scope. Name attributes and the intended scene, then agree how coded samples will be assessed. No additional round count or longer duration is automatic.
Who handles registration and safety testing?
Create a destination-specific responsibility matrix before committing. Agree what formula/fragrance/label information is provided, who performs qualified safety review or submissions, and which services are external. Use controlled access for confidential formulas; there is no universal buyer entitlement to the entire concentrate formula or standard turnkey documentation pack.
Is a pilot batch always necessary?
Have the technical/quality team determine appropriate development, pilot or line-trial evidence for the actual risks. A pilot can support the decision, but neither a fixed scale nor a guarantee against loss follows from the word “pilot.”
To review a private label perfume concept, Request a Quote with the completed brief and unresolved decisions. Confirm the team’s actual deliverables and approval responsibilities.